NCT05566197

Brief Summary

The goal of this randomized clinical trial is to evaluate the effect of Nusantara Diet (Low Calorie and Low Sodium) for Metabolic Syndrome. The main questions it aims to answer are:

  • How effective the Nusantara diet in reducing body mass index and body fat percentage?
  • How effective the Nusantara diet in affecting lipid profile and insulin resistance? Participants will be given this diet for a period of 56 days and undergo repeated outcome measurement. This study has a comparison group (no intervention) to see the difference of reduction or slope of changes in outcomes. We assumed that the Nusantara diet will reduce the metabolic syndrome indicators (anthropometry, lipid profile, and insulin resistance profile).

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jul 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 15, 2022

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

September 30, 2022

Completed
4 days until next milestone

First Posted

Study publicly available on registry

October 4, 2022

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2022

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2023

Completed
Last Updated

October 4, 2022

Status Verified

September 1, 2022

Enrollment Period

6 months

First QC Date

September 30, 2022

Last Update Submit

September 30, 2022

Conditions

Keywords

Diet NusantaraLow CalorieLow SodiumLipid ProfileInsulin Resistance

Outcome Measures

Primary Outcomes (4)

  • Body Mass Index

    Defined as body weight in kilogram defined by square of body height in meter. Higher number indicates obesity

    changes of body mass index from baseline to day 56

  • Lipid profile

    parameters of lipid (total cholesterol, LDL, HDL, Triglyceride) measured from blood sample

    changes of lipid profile from baseline to day 56

  • Homeostatic Model Assessment for Insulin Resistance (HOMA-IR)

    HOMA-IR was calculated according to the formula: fasting insulin x fasting glucose/22.5.

    changes of HOMA-IR from baseline to day 56

  • Body Fat Percentage

    Body Fat Percentage is the total mass of fat divided by total body mass, multiplied by 100. This is measured by Bioelectrical Impedance Analyzer.

    changes of Body Fat Percentage from baseline to day 56

Study Arms (2)

Intervention

EXPERIMENTAL

This group will receive dietary adjustment and nutrition counseling.

Dietary Supplement: Diet NusantaraBehavioral: Nutrition Counseling

Control

ACTIVE COMPARATOR

This group will receive standard diet and nutrition counseling.

Behavioral: Nutrition Counseling

Interventions

Diet NusantaraDIETARY_SUPPLEMENT

Diet Nusantara consists of 1700 kilocalories (or 500 kilocalories lower than basal energy expenditure) on first month and subsequent reduction for the following months (200 kilocalories). The participants should also limit the sodium intake not more than 2300 mg daily

Intervention

Nutrition counseling consists of the definition of balancing food, metabolic syndrome, exercise, and related health parameters.

ControlIntervention

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Fulfill the definition of metabolic syndrome
  • Blood Pressure\>135/85 mmHg
  • Central obesity with waist circumference for males\>90 cm or \>80 cm in females
  • Triglyceride level \>150 mg/dL, followed by HDL\<40 mg/dL
  • blood fasting glucose \>100 mg/dL

You may not qualify if:

  • pregnant or breastfeeding women
  • suffer from chronic disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Wahidin Sudirohusodo General Hospital

Makassar, South Sulawesi, 76124, Indonesia

RECRUITING

Related Publications (8)

  • Sigit FS, Tahapary DL, Trompet S, Sartono E, Willems van Dijk K, Rosendaal FR, de Mutsert R. The prevalence of metabolic syndrome and its association with body fat distribution in middle-aged individuals from Indonesia and the Netherlands: a cross-sectional analysis of two population-based studies. Diabetol Metab Syndr. 2020 Jan 7;12:2. doi: 10.1186/s13098-019-0503-1. eCollection 2020.

    PMID: 31921359BACKGROUND
  • Rochlani Y, Pothineni NV, Kovelamudi S, Mehta JL. Metabolic syndrome: pathophysiology, management, and modulation by natural compounds. Ther Adv Cardiovasc Dis. 2017 Aug;11(8):215-225. doi: 10.1177/1753944717711379. Epub 2017 Jun 22.

    PMID: 28639538BACKGROUND
  • Papamandjaris AA, MacDougall DE, Jones PJ. Medium chain fatty acid metabolism and energy expenditure: obesity treatment implications. Life Sci. 1998;62(14):1203-15. doi: 10.1016/s0024-3205(97)01143-0.

    PMID: 9570335BACKGROUND
  • Lipoeto NI, Agus Z, Oenzil F, Wahlqvist M, Wattanapenpaiboon N. Dietary intake and the risk of coronary heart disease among the coconut-consuming Minangkabau in West Sumatra, Indonesia. Asia Pac J Clin Nutr. 2004;13(4):377-84.

    PMID: 15563444BACKGROUND
  • de la Iglesia R, Loria-Kohen V, Zulet MA, Martinez JA, Reglero G, Ramirez de Molina A. Dietary Strategies Implicated in the Prevention and Treatment of Metabolic Syndrome. Int J Mol Sci. 2016 Nov 10;17(11):1877. doi: 10.3390/ijms17111877.

    PMID: 27834920BACKGROUND
  • Goossens GH. The Metabolic Phenotype in Obesity: Fat Mass, Body Fat Distribution, and Adipose Tissue Function. Obes Facts. 2017;10(3):207-215. doi: 10.1159/000471488. Epub 2017 Jun 1.

    PMID: 28564650BACKGROUND
  • Di Daniele N, Noce A, Vidiri MF, Moriconi E, Marrone G, Annicchiarico-Petruzzelli M, D'Urso G, Tesauro M, Rovella V, De Lorenzo A. Impact of Mediterranean diet on metabolic syndrome, cancer and longevity. Oncotarget. 2017 Jan 31;8(5):8947-8979. doi: 10.18632/oncotarget.13553.

    PMID: 27894098BACKGROUND
  • Gusnedi, Abdullah M, Witjaksono F, Mansyur M, Nurwidya F, Djuwita R, Dwiriani CM, Fahmida U. Promotion of optimized food-based recommendations to improve dietary practices and nutrient intakes among Minangkabau women of reproductive age with dyslipidemia. Asia Pac J Clin Nutr. 2020;29(2):334-347. doi: 10.6133/apjcn.202007_29(2).0016.

    PMID: 32674241BACKGROUND

MeSH Terms

Conditions

Metabolic SyndromeDiabetes MellitusHyperlipidemiasInsulin Resistance

Condition Hierarchy (Ancestors)

HyperinsulinismGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesDyslipidemiasLipid Metabolism Disorders

Study Officials

  • Agussalim Bukhari, MD.Phd

    Hasanuddin University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Agussalim Bukhari, MD. PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
masking is not feasible according to the study design.
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: The intervention will receive a package of dietary intervention + nutrition counseling, whereas the control group will receive only nutrition counseling.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Lecturer

Study Record Dates

First Submitted

September 30, 2022

First Posted

October 4, 2022

Study Start

July 15, 2022

Primary Completion

December 30, 2022

Study Completion

February 1, 2023

Last Updated

October 4, 2022

Record last verified: 2022-09

Data Sharing

IPD Sharing
Will not share

De-identified data in a form of publication supplement will be shared accordingly

Locations